Jinhua Wang

1.1k total citations
27 papers, 486 citations indexed

About

Jinhua Wang is a scholar working on Reproductive Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Jinhua Wang has authored 27 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Reproductive Medicine, 7 papers in Molecular Biology and 7 papers in Cancer Research. Recurrent topics in Jinhua Wang's work include Ovarian cancer diagnosis and treatment (6 papers), Endometriosis Research and Treatment (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Jinhua Wang is often cited by papers focused on Ovarian cancer diagnosis and treatment (6 papers), Endometriosis Research and Treatment (3 papers) and Cancer, Lipids, and Metabolism (3 papers). Jinhua Wang collaborates with scholars based in United States, China and Germany. Jinhua Wang's co-authors include Jeffrey S. Miller, Xianghua Luo, Bin Zhang, Bruce R. Blazar, Aimee Merino, Frank Cichocki, Xiaoxiang Chen, Fang Wang, Weijia Ding and Xuehua Kong and has published in prestigious journals such as Journal of Clinical Investigation, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Jinhua Wang

27 papers receiving 485 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinhua Wang United States 14 171 148 133 85 58 27 486
Gregory M. Chen United States 8 295 1.7× 163 1.1× 288 2.2× 68 0.8× 53 0.9× 10 667
Nupur Mukherjee India 17 415 2.4× 86 0.6× 202 1.5× 154 1.8× 32 0.6× 33 689
Stéfanie Schneider Germany 11 230 1.3× 99 0.7× 85 0.6× 66 0.8× 22 0.4× 13 485
Hengzi Sun China 12 181 1.1× 30 0.2× 52 0.4× 101 1.2× 46 0.8× 22 343
Qiao‐Yang Sun Singapore 15 446 2.6× 65 0.4× 105 0.8× 80 0.9× 39 0.7× 23 675
Chunyan Hu China 16 279 1.6× 173 1.2× 115 0.9× 130 1.5× 12 0.2× 24 614
Luyao Zhang China 7 112 0.7× 25 0.2× 87 0.7× 44 0.5× 30 0.5× 14 392
Ayshamgul Hasim China 15 387 2.3× 124 0.8× 105 0.8× 206 2.4× 11 0.2× 38 613
James A. Dowdle United States 6 439 2.6× 50 0.3× 86 0.6× 128 1.5× 19 0.3× 7 606

Countries citing papers authored by Jinhua Wang

Since Specialization
Citations

This map shows the geographic impact of Jinhua Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinhua Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinhua Wang more than expected).

Fields of papers citing papers by Jinhua Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinhua Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinhua Wang. The network helps show where Jinhua Wang may publish in the future.

Co-authorship network of co-authors of Jinhua Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Jinhua Wang. A scholar is included among the top collaborators of Jinhua Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinhua Wang. Jinhua Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sena, Laura A., Benjamin Miller, John R. Lozada, et al.. (2024). Divergent immune microenvironments in two tumor nodules from a patient with mismatch repair-deficient prostate cancer. npj Genomic Medicine. 9(1). 7–7. 5 indexed citations
2.
Ren, Liwen, Li Wan, Yizhi Zhang, et al.. (2024). Interferon Gamma Inducible Protein 30: from biological functions to potential therapeutic target in cancers. Cellular Oncology. 47(5). 1593–1605. 2 indexed citations
3.
Chen, Lihong, et al.. (2024). Analysis of Clinical Characteristics and Prognostic Factors Related to EMs Correlation in Ovarian Cancer Patients.. PubMed. 30(8). 104–107. 1 indexed citations
4.
Ali, Atef, John R. Lozada, Xiaolei Shi, et al.. (2023). ALAN is a computational approach that interprets genomic findings in the context of tumor ecosystems. Communications Biology. 6(1). 417–417. 4 indexed citations
5.
Sarver, Aaron L., Lauren J. Mills, Kelly M. Makielski, et al.. (2023). Distinct mechanisms of PTEN inactivation in dogs and humans highlight convergent molecular events that drive cell division in the pathogenesis of osteosarcoma. Cancer Genetics. 276-277. 1–11. 6 indexed citations
6.
Li, Liping, Qiwen Hu, Chen Jin, et al.. (2023). Polyphyllin I inhibits endometriosis in vitro by inducing apoptosis and autophagy via the inactivation of AKT/mTOR signalling pathway. Natural Product Research. 39(5). 1095–1100. 1 indexed citations
7.
Shi, Xiaolei, Sylvan C. Baca, Justin M. Drake, et al.. (2022). Integrative molecular analyses define correlates of high B7-H3 expression in metastatic castrate-resistant prostate cancer. npj Precision Oncology. 6(1). 80–80. 18 indexed citations
8.
Wang, Jinhua, et al.. (2022). Value of Intravoxel Incoherent Motion (IVIM) Imaging for Differentiation between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma. Contrast Media & Molecular Imaging. 2022(1). 1504463–1504463. 4 indexed citations
9.
Walmsley, Scott J., Jingshu Guo, Paari Murugan, et al.. (2021). Comprehensive Analysis of DNA Adducts Using Data-Independent wSIM/MS2 Acquisition and wSIM-City. Analytical Chemistry. 93(16). 6491–6500. 17 indexed citations
10.
Hussain, Tabish, Arpit Rao, Hifzur R. Siddique, et al.. (2020). Anti-S100A4 Antibody Therapy Is Efficient in Treating Aggressive Prostate Cancer and Reversing Immunosuppression: Serum and Biopsy S100A4 as a Clinical Predictor. Molecular Cancer Therapeutics. 19(12). 2598–2611. 13 indexed citations
11.
Wang, Jinhua, et al.. (2020). <p>Emodin Reverses the Epithelial–Mesenchymal Transition of Human Endometrial Stromal Cells by Inhibiting ILK/GSK-3β Pathway</p>. Drug Design Development and Therapy. Volume 14. 3663–3672. 8 indexed citations
12.
Ferrari, Marina G., Li Wang, Paari Murugan, et al.. (2020). Identifying and treating ROBO1−ve/DOCK1+ve prostate cancer: An aggressive cancer subtype prevalent in African American patients. The Prostate. 80(13). 1045–1057. 5 indexed citations
13.
Parray, Aijaz, Tabish Hussain, Marina G. Ferrari, et al.. (2019). Characterization of Novel Murine and Human PDAC Cell Models: Identifying the Role of Intestine Specific Homeobox Gene ISX in Hypoxia and Disease Progression. Translational Oncology. 12(8). 1056–1071. 2 indexed citations
14.
Merino, Aimee, Bin Zhang, Xianghua Luo, et al.. (2019). Chronic stimulation drives human NK cell dysfunction and epigenetic reprograming. Journal of Clinical Investigation. 129(9). 3770–3785. 127 indexed citations
15.
Winterhoff, Boris, Stefan Kommoss, Florian Heitz, et al.. (2018). Developing a Clinico-Molecular Test for Individualized Treatment of Ovarian Cancer: The interplay of Precision Medicine Informatics with Clinical and Health Economics Dimensions.. eScholarship (California Digital Library). 2018. 1093–1102. 5 indexed citations
16.
Giles, Keith M., Allison Izsak, Eleazar Vega‐Saenz de Miera, et al.. (2018). Revisiting the Clinical and Biologic Relevance of Partial PTEN Loss in Melanoma. Journal of Investigative Dermatology. 139(2). 430–438. 20 indexed citations
17.
Wang, Fang, et al.. (2013). CA-125–indicated asymptomatic relapse confers survival benefit to ovarian cancer patients who underwent secondary cytoreduction surgery. Journal of Ovarian Research. 6(1). 14–14. 26 indexed citations
18.
Wang, Jinhua, Ashok Sharma, Sharad Ghamande, et al.. (2013). Serum Protein Profile at Remission Can Accurately Assess Therapeutic Outcomes and Survival for Serous Ovarian Cancer. PLoS ONE. 8(11). e78393–e78393. 11 indexed citations
19.
Xu, Xia, Yan Wang, Fang Wang, et al.. (2013). Nadir CA-125 level as prognosis indicator of high-grade serous ovarian cancer. Journal of Ovarian Research. 6(1). 31–31. 18 indexed citations
20.
Zhao, Yibing, Jinhua Wang, Xiaoxiang Chen, Yuzhong Wu, & Qiang Wu. (2012). Values of Three Different Preoperative Regimens in Comprehensive Treatment For Young Patients with Stage Ib2 Cervical Cancer. Asian Pacific Journal of Cancer Prevention. 13(4). 1487–1489. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gregory M. Chen Breakdown of academic impact, for papers by Nupur Mukherjee Breakdown of academic impact, for papers by Stéfanie Schneider Breakdown of academic impact, for papers by Hengzi Sun Breakdown of academic impact, for papers by Qiao‐Yang Sun Breakdown of academic impact, for papers by Chunyan Hu Breakdown of academic impact, for papers by Luyao Zhang Breakdown of academic impact, for papers by Ayshamgul Hasim Breakdown of academic impact, for papers by James A. Dowdle
Rankless by CCL
2026